| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699977 | Clinical Oncology | 2007 | 5 Pages |
Abstract
Elevated plasma levels of d-dimer in patients with lung cancer are associated with decreased survival and a poor response to treatment. Pre-treatment for the d-dimer level may be useful in the prediction of survival and the response to treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G. Altiay, A. Ciftci, M. Demir, Z. Kocak, N. Sut, E. Tabakoglu, O.N. Hatipoglu, T. Caglar,